65 related articles for article (PubMed ID: 8653191)
1. Cost recovery and improved drug availability in Niger--implications for total patient treatment costs.
Wouters A; Kouzis A
Health Econ; 1996; 5(1):37-59. PubMed ID: 8653191
[TBL] [Abstract][Full Text] [Related]
2. Improving quality through cost recovery in Niger.
Wouters A
Health Policy Plan; 1995 Sep; 10(3):257-70. PubMed ID: 10151843
[TBL] [Abstract][Full Text] [Related]
3. The impact of alternative cost recovery schemes on access and equity in Niger.
Diop F; Yazbeck A; Bitrán R
Health Policy Plan; 1995 Sep; 10(3):223-40. PubMed ID: 10151841
[TBL] [Abstract][Full Text] [Related]
4. The cost of dengue hemorrhagic fever in Thailand.
Okanurak K; Sornmani S; Indaratna K
Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):711-7. PubMed ID: 9656390
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
[TBL] [Abstract][Full Text] [Related]
7. Acute coronary syndromes in Europe: 1-year costs and outcomes.
Taylor MJ; Scuffham PA; McCollam PL; Newby DE
Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
[TBL] [Abstract][Full Text] [Related]
8. How does Cash and Counseling affect costs?
Dale SB; Brown RS
Health Serv Res; 2007 Feb; 42(1 Pt 2):488-509. PubMed ID: 17244294
[TBL] [Abstract][Full Text] [Related]
9. [Cost measurement based on a cost diary in patients with inflammatory bowel disease].
Rösch M; Leidl R; Tirpitz Cv; Reinshagen M; Adler G; König HH
Z Gastroenterol; 2002 Apr; 40(4):217-28. PubMed ID: 11961730
[TBL] [Abstract][Full Text] [Related]
10. The effects of medical group practice and physician payment methods on costs of care.
Kralewski JE; Rich EC; Feldman R; Dowd BE; Bernhardt T; Johnson C; Gold W
Health Serv Res; 2000 Aug; 35(3):591-613. PubMed ID: 10966087
[TBL] [Abstract][Full Text] [Related]
11. Beyond the myths: finding benefit design solutions that address the true costs of high healthcare use.
Willey VJ; Kopenski F; Lawless GD
Am J Manag Care; 2008 Jul; 14(8 Suppl):S252-63. PubMed ID: 18672956
[TBL] [Abstract][Full Text] [Related]
12. Infliximab drug and infusion costs among patients with Crohn's disease in a commercially-insured setting.
Ollendorf DA; Lidsky L
Am J Ther; 2006; 13(6):502-6. PubMed ID: 17122530
[TBL] [Abstract][Full Text] [Related]
13. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
Krummenauer F; Günther KP; Witzlebf WC
Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
[TBL] [Abstract][Full Text] [Related]
14. [Family expenses caused by pediatric hospitalization in Niamey (Niger)].
Barennes H; Azzaratou I
Sante; 1998; 8(6):405-10. PubMed ID: 10064912
[TBL] [Abstract][Full Text] [Related]
15. [What does the individual patient cost? CPP--the Cost Per Patient method--is the answer].
Heurgren M; Nilsson H; Erlö C; Sjöli P
Lakartidningen; 2003 Oct; 100(42):3312-5. PubMed ID: 14619041
[No Abstract] [Full Text] [Related]
16. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.
Hamer HM; Spottke A; Aletsee C; Knake S; Reis J; Strzelczyk A; Oertel WH; Rosenow F; Dodel R
Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
[TBL] [Abstract][Full Text] [Related]
18. Asthma treatment costs using inhaled corticosteroids.
Holzer SS; Engelhart L; Crown WH; L'Herrou TA; Kennedy ST
Am J Manag Care; 1997 Jun; 3(6):891-7. PubMed ID: 10170293
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of prescription practices and of the rational use of medicines in Niger].
Mallet HP; Njikam A; Scouflaire SM
Sante; 2001; 11(3):185-93. PubMed ID: 11641083
[TBL] [Abstract][Full Text] [Related]
20. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
